Neogenomics

Forecast & Rating12 analysts currently cover Neogenomics, with about 75.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.55, about 31.8% upside from the current price of $16.35. Price targets range from $16.00 to $35.00 — a wide spread, showing clear disagreement over just how much Neogenomics can rise. Historically, about 37.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Neogenomics closely still see room for the stock to rise. Data as of Oct 6, 2026; for reference only and not investment advice.